Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
140.5 USD | +0.77% | -0.05% | +6.62% |
28/05 | Neurocrine Biosciences Says CEO Kevin Gorman Retiring | MT |
28/05 | Neurocrine founder-CEO Gorman to retire in October | RE |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.62% | 1.41TCr | |
+9.83% | 12TCr | |
+10.80% | 10TCr | |
-10.84% | 2.27TCr | |
-1.69% | 2.18TCr | |
-10.23% | 1.82TCr | |
-41.92% | 1.65TCr | |
-15.11% | 1.6TCr | |
+17.53% | 1.07TCr | |
-30.73% | 759.76Cr |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- Transcript : Neurocrine Biosciences, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 11